24 October 2018 - Thousands of Australians will have their vision saved or prolonged through increased access to eye medications.
Drugs costing up to $7000 a year will be listed on the Pharmaceutical Benefits Scheme to combat a range of eye conditions that lead to deteriorating vision for more than 4,500 Australians a year.
From November 1, Ozurdex, which costs $1,350 a script, will be subsidised for the treatment of blocked veins in the retina due to eye tumours and made available for $39.50.